Cervical Artery Dissection
7
2
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
29%
2 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (7)
Defining the Basis of Fibromuscular Dysplasia (FMD)
Antithrombotic Treatment Strategies in Cervical Artery Dissection
Risk of Recurrent CeAD After Pregnancy
Biomarkers and Antithrombotic Treatment in Cervical Artery Dissection - TREAT-CAD
Risk of Recurrence of Cervical Artery Dissection During Pregnancy and Puerperium
To Determine the Feasibility of a Clinical Trial Comparing Anticoagulants Versus Antiplatelets in the Acute Treatment of Patients With Cervical Artery Dissection
Looking For Genetic and Environmental Risk Factors and Therapeutic Aspects in Cervical Artery Dissections